Connect with us

Health

EU seals deal on Critical Medicines Act after marathon talks

SHARE:

Published

1 month ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

As anticipated in yesterday’s (11 May) ‘Inside EU Health’, the Council and Parliament were able to reach a provisional agreement on the Critical Medicines Act (CMA). The deal was sealed at 6:00 this morning after a punishing 12 hours of negotiations. European policy making is not for the faint-hearted.

“Through today’s agreement we are placing patients’ interests firmly at the centre, strengthening Europe’s resilience and boosting the competitiveness of our pharmaceutical sector,” said rapporteur Tomislav Sokol (Croatia, EPP). “By introducing collaborative procurement at the EU level, we are taking concrete action to address shortages and ensure security of supply.

Missing piece in pharma legislation
Many of the issues that the Critical Medicines Act seeks to address: accessibility, affordability and availability of medicines were areas that were not fully agreed on in the General Pharmaceutical Legislation (GPL). It was hoped that the CMA could address some of the GPL’s shortcomings.

"The Critical Medicines Act is closely linked...

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending